Harry Destecroix, co-founder and managing partner of SCVC, invests in pre-seed and seed-stage deep tech. See portfolio, sector focus and contact routes.
Harry Destecroix, co-founder and managing partner of SCVC, invests in pre-seed and seed-stage deep tech startups, primarily in biotech, quantum technology, AI, and semiconductors, with initial check sizes of $500,000 to $3 million and follow-on funding up to $7 million. His notable portfolio includes VyperCore (RISC-V processors), Delta g (quantum gravity sensors), Isomab (biotech), and Scarlet Therapeutics (red blood cell-based therapeutics). Destecroix’s distinctive thesis centers on backing founder-led university spin-outs to drive the “next major industrial revolution” by turning scientific breakthroughs in health and climate into commercial ventures.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Bristol.
Investors like Harry Destecroix · Full investor directory · Investor access · Company funding database